July 17, 2018: Agreement will meet increased demand for more targeted and personalized medicines currently driving growth and development in the mAb manufacturing market and offer a complete solution to customers
September 3, 2018: Celltheon and Pall to provide an integrated, cost-effective, time efficient end-to-end solution for research and bioproduction to expedite drug development and provide solutions for unmet needs in bioprocessing
June 15, 2015: Announcing Pall's signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications
January 29, 2018: New name reinforces Pall's commitment to providing standard configurable single-use, stainless steel and hybrid technologies for fed-batch and continuous processes across upstream, downstream and formulation and filling applications in biotech
October 5, 2016: Launch of new product designed for linear scale-up of an existing PD-scale continuous purification process to a GMP-compliant process-scale continuous purification using feedstreams derived from fed batch bioreactors of up to 2000 liter volume
September 25, 2017: Announcing three new additions to the Allegro™ single-use chromatography and Cadence™ continuous bioprocessing product portfolios, to be showcased this week at the BPI 2017 event in Boston
November 26, 2018: Cobra and Pall to make commercialisation of gene therapies safer, faster, and cheaper than ever before, help increase patient access to gene therapy and further establish best practices in manufacturing
March 19, 2019: New lab will serve as a dedicated platform where the industry can access shared resources including equipment, expertise and project work to find innovative solutions to manufacturing needs for biologic medicines, such as cell-based immunotherapies
September 24, 2018: New collaboration to see G-CON PODs customized with Pall technologies, addressing customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localization of manufacturing
September 25, 2017: Brammer Bio utilizes Pall's critical process solutions and process support, to help focus on building on more than 100 executed projects and 150 clinical cell and gene therapy lots in Florida, including many first-in-human trials
November 9, 2017: New training courses starting early 2018 focused on continuous bioprocessing advances will detail the state of the industry, and the advantages and practical implications of transitioning from batch to semi- or fully-continuous bioprocess methodologies
December 18, 2018: New centre to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, and to provide technology solutions that meet current needs, while offering some of the most progressive technological solutions for the future
Pall Corporation is an industry leader and manufacturer of proprietary filtration, separation and purification products and solutions. Pall offers a wide range of filters to meet your fluid management needs.
Pall Aerospace has the expertise in protecting every critical piece of fluid equipment on an aircraft and experience with virtually every aerospace and defense program that requires fluid filtration and separation.
Chemicals and polymers require a significant amount of filtration, separation, and purification during the manufacturing process. Discover why we are the trusted industry leader when it comes to filtration solutions for chemicals and polymers.
Explore the various industrial manufacuring filtration segements that we serve. Our products and services solve challenges that directly impact operation uptime, maintenance frequency, product quality, life of capital equipment and overall business performance.
Advanced oil & gas filtration solutions allow industries to deliver enhanced filtration performance across the upstream, midstream, and downstream industries for reduced operating costs and improved process efficiency